ASRS
MLYS icon

Arizona State Retirement System’s Mineralys Therapeutics MLYS Stock Holding History

Arizona State Retirement System’s Portfolio MLYS Stock Details MLYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$340K Sell
12,542
-458
-4% -$13.4K ﹤0.01% 1665
2025
Q4 		$472K Buy
13,000
+2,393
+23% +$96K ﹤0.01% 1515
2025
Q3 		$402K Buy
+10,607
New +$229K ﹤0.01% 1635

Other funds holding MLYS

CP
Catalys Pacific Tokyo, Japan $231M AUM 83.19% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Arizona State Retirement System's MLYS Position: Q1 2026 in Review

Arizona State Retirement System reduced its Mineralys Therapeutics (MLYS) stake by 3.5% in Q1 2026, selling an estimated $13.4K and leaving 12,542 shares worth $340K. The position accounts for ﹤0.01% of the portfolio, ranked #1665.

Arizona State Retirement System first reported a position in MLYS in Q3 2025 and has held it in 3 quarters since. The position peaked at $472K in Q4 2025. 214 funds tracked by Wall St. Rank hold MLYS as of Q1 2026.

  • Arizona State Retirement System held 12,542 shares of Mineralys Therapeutics worth $340K as of Q1 2026.
  • Arizona State Retirement System sold 458 Mineralys Therapeutics shares in Q1 2026, an estimated $13.4K.
  • Mineralys Therapeutics made up ﹤0.01% of Arizona State Retirement System's portfolio in Q1 2026, its #1665 holding.
  • Arizona State Retirement System first reported a position in Mineralys Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • Arizona State Retirement System's Mineralys Therapeutics position peaked at $472K in Q4 2025.
  • 214 funds tracked by Wall St. Rank held Mineralys Therapeutics as of Q1 2026.

Based on Arizona State Retirement System's 13F filing for Q1 2026, filed 1 May 2026.